Home > Research > Publications & Outputs > Complement inhibitors for myasthenia gravis in ...

Research

Electronic data

  • Fulltext

    Final published version, 229 KB, fulltext

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

Keywords

View graph of relations

Complement inhibitors for myasthenia gravis in adults

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Complement inhibitors for myasthenia gravis in adults. / White, Laura M; Clay, Fiona J; Forbes, Anne-Marie et al.
In: Cochrane Database of Systematic Reviews, Vol. 2025, No. 7, CD016098, 08.07.2025.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

White, LM, Clay, FJ, Forbes, A-M, Keh, RYS, Lilleker, JB, Spillane, J, Storms, K, Sussman, J & Dodd, KC 2025, 'Complement inhibitors for myasthenia gravis in adults', Cochrane Database of Systematic Reviews, vol. 2025, no. 7, CD016098. https://doi.org/10.1002/14651858.cd016098

APA

White, L. M., Clay, F. J., Forbes, A.-M., Keh, R. Y. S., Lilleker, J. B., Spillane, J., Storms, K., Sussman, J., & Dodd, K. C. (2025). Complement inhibitors for myasthenia gravis in adults. Cochrane Database of Systematic Reviews, 2025(7), Article CD016098. https://doi.org/10.1002/14651858.cd016098

Vancouver

White LM, Clay FJ, Forbes AM, Keh RYS, Lilleker JB, Spillane J et al. Complement inhibitors for myasthenia gravis in adults. Cochrane Database of Systematic Reviews. 2025 Jul 8;2025(7):CD016098. doi: 10.1002/14651858.cd016098

Author

White, Laura M ; Clay, Fiona J ; Forbes, Anne-Marie et al. / Complement inhibitors for myasthenia gravis in adults. In: Cochrane Database of Systematic Reviews. 2025 ; Vol. 2025, No. 7.

Bibtex

@article{499f3b30951241c2998c578481dd3baf,
title = "Complement inhibitors for myasthenia gravis in adults",
abstract = "This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of complement inhibitors for treating myasthenia gravis in adults compared with control treatment (placebo or standard care). ",
keywords = "Humans, Myasthenia Gravis, Adult, Complement Inactivating Agents, Randomized Controlled Trials as Topic, Antibodies, Monoclonal, Humanized",
author = "White, {Laura M} and Clay, {Fiona J} and Anne-Marie Forbes and Keh, {Ryan Yann Shern} and Lilleker, {James B} and Jennifer Spillane and Karen Storms and Jon Sussman and Dodd, {Katherine C}",
year = "2025",
month = jul,
day = "8",
doi = "10.1002/14651858.cd016098",
language = "English",
volume = "2025",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - Complement inhibitors for myasthenia gravis in adults

AU - White, Laura M

AU - Clay, Fiona J

AU - Forbes, Anne-Marie

AU - Keh, Ryan Yann Shern

AU - Lilleker, James B

AU - Spillane, Jennifer

AU - Storms, Karen

AU - Sussman, Jon

AU - Dodd, Katherine C

PY - 2025/7/8

Y1 - 2025/7/8

N2 - This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of complement inhibitors for treating myasthenia gravis in adults compared with control treatment (placebo or standard care). 

AB - This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of complement inhibitors for treating myasthenia gravis in adults compared with control treatment (placebo or standard care). 

KW - Humans

KW - Myasthenia Gravis

KW - Adult

KW - Complement Inactivating Agents

KW - Randomized Controlled Trials as Topic

KW - Antibodies, Monoclonal, Humanized

U2 - 10.1002/14651858.cd016098

DO - 10.1002/14651858.cd016098

M3 - Journal article

VL - 2025

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 7

M1 - CD016098

ER -